CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs | MicrobiomeTrials
CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-22Est. Completion: 2026-12-20
Enrollment target: 147 participants
Locations
North Park Podiatry, San Diego, California, United States
Solutions Medical Research, Coral Gables, Florida, United States
NAR Medical and Research, Miami, Florida, United States
Nova Medical Services - Research Division LLC, Miami, Florida, United States
Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States
St. Louis Foot and Ankle, LLC, St Louis, Missouri, United States
Hope Vascular and Podiatry, Houston, Texas, United States